| |||||||
Type Mutant Stock; Targeted Mutation; Additional information on Genetically Engineered and Mutant Mice. Visit our online Nomenclature tutorial. Species laboratory mouse Generation B6129N1 F3 Donating Investigator Edward Ginns, National Institutes of Health Appearance
white-bellied agouti
Related Genotype: Aw/Aw
black
Related Genotype: a/aDescription
Mice homozygous for this mutation die neonatally due to a defect in the skin vapor barrier. Homozygous mice are small at birth and display an abnormal respiration that progresses to cyanosis and death. This phenotype is similar to a severe infantile form of Gaucher's disease in humans.
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| 101045 B6129SF2/J | (approximate) | |
| Considerations for Choosing Controls | ||
Strains carrying Gbatm1Nsb allele
003321 B6.129S6-Gbatm1Nsb/J View Strains carrying Gbatm1Nsb (1 strain)
View Related Disease (OMIM) Terms
Related Disease (OMIM) Terms
Gaucher Disease, Type II - Models with phenotypic similarity to human disease where etiologies involve orthologs.1
1 Human genes are associated with this disease. Orthologs of those genes appear in the mouse genotype(s).
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
Gbatm1Nsb/Gbatm1Nsb
involves: 129S/SvEv * C57BL/6
- lethality-prenatal/perinatal
- perinatal lethality (MGI Ref ID J:1100)
- behavior/neurological phenotype
- abnormal food intake (MGI Ref ID J:1100)
- decreased feeding
- akinesia (MGI Ref ID J:1100)
- growth/size phenotype
- reduced fetal size (MGI Ref ID J:1100)
- underweight, evident at birth
- hematopoietic system phenotype
- abnormal macrophage morphology (MGI Ref ID J:1100)
- macrophages in liver, bone marrow, spleen, and brain show lysosomal lipid accumulation
- homeostasis/metabolism phenotype
- cyanosis (MGI Ref ID J:1100)
- immune system phenotype
- abnormal macrophage morphology (MGI Ref ID J:1100)
- macrophages in liver, bone marrow, spleen, and brain show lysosomal lipid accumulation
- respiratory system phenotype
- abnormal respiration (MGI Ref ID J:1100)
- respire abnormally from birth
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:Gbatm1Nsb related
Dermatology Research
Skin and Hair Texture Defects
Mouse/Human Gene Homologs
Gaucher disease, type I
| Allele Symbol | Gbatm1Nsb | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, Edward Ginns | ||
| Allele Type | Targeted (knock-out) | ||
| Mutation Made By | Edward Ginns, National Institutes of Health | ||
| Strain of Origin | 129S/SvEv-Gpi1c | ||
| ES Cell Line Name | CCE/EK.CCE | ||
| ES Cell Line Strain | 129S/SvEv-Gpi1 | ||
| Gene Symbol and Name | Gba, glucosidase, beta, acid | ||
| Chromosome | 3 | ||
| Gene Common Name(s) | GBA1; GC; GCB; GCase; GLUC; betaGC; glucocerebrosidase; | ||
| General Note | Homozygotes for the mutation die within 24 hours after birth, and store glucocerebroside in reticuloendothelial cell lysosomes (J:1100). Epidermal effects of Gbatm1Nsb include elevated glucosylceremide, diminished ceremide, and incompetent barrier function (J:17577). | ||
| Molecular Note | A neomycin resistance cassette was inserted into exons 9 and 10 of the gene, which encode part of the active site of the enzyme. Enzymatic activity of the targeted protein in homozygous mutant mice was less than 4% of controls. [MGI Ref ID J:1100] | ||
Genotyping Protocols
Gbatm1Nsb, STD PCR, vers. 1
Helpful Links
Optimizing PCR Protocols
Tybulewicz VL; Tremblay ML; LaMarca ME; Willemsen R; Stubblefield BK; Winfield S; Zablocka B; Sidransky E; Martin BM; Huang SP; Mintzer KA; Westphal H; Mulligan RC; Ginns EI. 1992. Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene. Nature 357(6377):407-10. [PubMed: 1594045] [MGI Ref ID J:1100]
Willemsen R; Tybulewicz V; Sidransky E; Eliason WK; Martin BM; LaMarca ME; Reuser AJ; Tremblay M; Westphal H; Mulligan RC; Ginns EI. 1995. A biochemical and ultrastructural evaluation of the type 2 Gaucher mouse. Mol Chem Neuropathol 24(2-3):179-92. [PubMed: 7632321] [MGI Ref ID J:26608]
Gbatm1Nsb relatedBornstein P; McKinney CE; LaMarca ME; Winfield S; Shingu T; Devarayalu S; Vos HL; Ginns EI. 1995. Metaxin, a gene contiguous to both thrombospondin 3 and glucocerebrosidase, is required for embryonic development in the mouse: implications for Gaucher disease. Proc Natl Acad Sci U S A 92(10):4547-51. [PubMed: 7753840] [MGI Ref ID J:25197]
Holleran WM; Ginns EI; Menon GK; Grundmann JU; Fartasch M; McKinney CE; Elias PM; Sidransky E. 1994. Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease. J Clin Invest 93(4):1756-64. [PubMed: 8163674] [MGI Ref ID J:17577]
Kim EY; Hong YB; Go SH; Lee B; Jung SC. 2006. Downregulation of neurotrophic factors in the brain of a mouse model of Gaucher disease; implications for neuronal loss in Gaucher disease. Exp Mol Med 38(4):348-56. [PubMed: 16953113] [MGI Ref ID J:115894]
Orvisky E; Sidransky E; McKinney CE; Lamarca ME; Samimi R; Krasnewich D; Martin BM; Ginns EI. 2000. Glucosylsphingosine accumulation in mice and patients with type 2 Gaucher disease begins early in gestation. Pediatr Res 48(2):233-7. [PubMed: 10926300] [MGI Ref ID J:102303]
Willemsen R; Tybulewicz V; Sidransky E; Eliason WK; Martin BM; LaMarca ME; Reuser AJ; Tremblay M; Westphal H; Mulligan RC; Ginns EI. 1995. A biochemical and ultrastructural evaluation of the type 2 Gaucher mouse. Mol Chem Neuropathol 24(2-3):179-92. [PubMed: 7632321] [MGI Ref ID J:26608]
Xu YH; Quinn B; Witte D; Grabowski GA. 2003. Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease. Am J Pathol 163(5):2093-101. [PubMed: 14578207] [MGI Ref ID J:86334]
Colony Maintenance
Diet Information LabDiet® 5K52/5K67
| Pricing for USA, Canada and Mexico shipping destinations |
|
Animals Provided
Price (US dollars $) Cryorecovery Fee $1900.00 At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.
| Pricing for International shipping destinations |
|
Animals Provided
Price (US dollars $) Cryorecovery Fee $2470.00 At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.
| Standard Supply | Cryopreserved. Ready for recovery. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| 101045 B6129SF2/J | (approximate) | |
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.